Biocare Diagnostics Ltd.

Biocare Diagnostics Ltd is a high-tech enterprise specializing in the research, development, production, and sales of raw materials for in vitro diagnostic (IVD) reagents. Our main product portfolio includes high-quality antigens, antibodies, and their conjugates, which are widely used in the production of IVD reagents across multiple detection platforms such as colloidal gold, ELISA, chemiluminescence, immunoturbidimetry, fluorescence immunochromatography, microfluidics, and quantum dots. Over more than a decade of continuous innovation, Biocare has developed over 150 matched antibody pairs suitable for diagnostic reagent manufacturing, with more than 50 pairs reaching single-batch production yields of tens of grams. This broad product coverage, combined with large-scale manufacturing capability, provides our customers with a distinct competitive advantage in both quality and cost. Biocare was recognized as a National High-Tech Enterprise in 2019 and ranked among the Top 50 Innovative Enterprises in Zhuhai Xiangzhou District’s “Top 100 High-Tech Enterprises” in 2020. On July 15, 2021, we achieved ISO 13485：2016 quality management system certification for the R&D, production, and sales of antigens and antibodies for IVD use. In December 2022, we successfully renewed our National High-Tech Enterprise status and were honored as a Provincial Innovative SME and a Provincial “Specialized, Refined, and Innovative” SME, while again being listed among Xiangzhou District’s Top 100 High-Tech Enterprises. Driven by quality, innovation, and customer trust, Biocare continues to provide reliable raw materials that empower the global diagnostics industry.